MedTrace Logo

RhinAV_Evaluation of Treatments for Acute Viral Rhinitis, Rhinosinusitis, and Rhinopharyngitis

NCT07383493 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2026-02-03

No results posted yet for this study

Summary

The objective of this study is to conduct post-marketing clinical follow-up of four products: NS, NHE, NHG, and PIR. This follow-up will consist of collecting clinical data in real-life conditions to confirm the tolerance, safety, and efficacy of medical devices used in the treatment of acute viral rhinitis, rhinosinusitis, and rhinopharyngitis, while also assessing the benefit/risk ratio of the products.

Conditions

  • Rhinitis
  • Rhinosinusitis
  • Rhinitis Acute
  • Rhinitis Viral
  • Rhinosinusitis Acute
  • Rhinopharyngitis

Interventions

DEVICE

PIR

Patients included in the "PIR" arm will receive the medical device of the same name.

DEVICE

NS

Patients included in the "NS" arm will receive the medical device of the same name.

DEVICE

NHE

Patients included in the "NHE" arm will receive the medical device of the same name.

DEVICE

NHG

Patients included in the "NHG" arm will receive the medical device of the same name.

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Lise Laclautre · University Hospital, Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-02-28
Primary Completion
2027-03-31
Completion
2027-03-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07383493 on ClinicalTrials.gov